These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8389849)

  • 1. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection.
    Podell M; Oglesbee M; Mathes L; Krakowka S; Olmstead R; Lafrado L
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):758-71. PubMed ID: 8389849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats.
    Podell M; Hayes K; Oglesbee M; Mathes L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):332-40. PubMed ID: 9342252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery.
    Liu P; Hudson LC; Tompkins MB; Vahlenkamp TW; Colby B; Rundle C; Meeker RB
    J Neurovirol; 2006 Aug; 12(4):294-306. PubMed ID: 16966220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological abnormalities associated with feline immunodeficiency virus infection.
    Phillips TR; Prospero-Garcia O; Puaoi DL; Lerner DL; Fox HS; Olmsted RA; Bloom FE; Henriksen SJ; Elder JH
    J Gen Virol; 1994 May; 75 ( Pt 5)():979-87. PubMed ID: 8176384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow accessory cell infection and alterations in hematopoiesis accompany severe neutropenia during experimental acute infection with feline immunodeficiency virus.
    Linenberger ML; Beebe AM; Pedersen NC; Abkowitz JL; Dandekar S
    Blood; 1995 Feb; 85(4):941-51. PubMed ID: 7849316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
    Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
    Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal lobe neuronal injury correlates to altered function in FIV-infected cats.
    Podell M; Maruyama K; Smith M; Hayes KA; Buck WR; Ruehlmann DS; Mathes LE
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):10-8. PubMed ID: 10534142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection.
    Barr MC; Huitron-Resendiz S; Selway DR; Henriksen SJ; Phillips TR
    J Infect Dis; 2000 Feb; 181(2):576-86. PubMed ID: 10669341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific viral distribution and neuropathology of feline immunodeficiency virus.
    Miller C; Bielefeldt-Ohmann H; MacMillan M; Huitron-Resendiz S; Henriksen S; Elder J; VandeWoude S
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):282-91. PubMed ID: 21715019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.
    Pedersen NC; Leutenegger CM; Woo J; Higgins J
    Vet Immunol Immunopathol; 2001 May; 79(1-2):53-67. PubMed ID: 11356250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats.
    Hayes KA; Wilkinson JG; Frick R; Francke S; Mathes LE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):114-22. PubMed ID: 7749786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
    Hayes KA; Lafrado LJ; Erickson JG; Marr JM; Mathes LE
    J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):127-34. PubMed ID: 8381867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.
    de Rozières S; Swan CH; Sheeter DA; Clingerman KJ; Lin YC; Huitron-Resendiz S; Henriksen S; Torbett BE; Elder JH
    Retrovirology; 2004 Nov; 1():38. PubMed ID: 15555065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain.
    Kohmoto M; Uetsuka K; Ikeda Y; Inoshima Y; Shimojima M; Sato E; Inada G; Toyosaki T; Miyazawa T; Doi K; Mikami T
    J Vet Med Sci; 1998 Mar; 60(3):315-21. PubMed ID: 9560779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR.
    Phillips TR; Prospero-Garcia O; Wheeler DW; Wagaman PC; Lerner DL; Fox HS; Whalen LR; Bloom FE; Elder JH; Henriksen SJ
    J Neurovirol; 1996 Dec; 2(6):388-96. PubMed ID: 8972420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of feline immunodeficiency virus from infected queens to kittens.
    Wasmoen T; Armiger-Luhman S; Egan C; Hall V; Chu HJ; Chavez L; Acree W
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):83-93. PubMed ID: 1337404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases.
    Dua N; Reubel G; Moore PF; Higgins J; Pedersen NC
    Vet Immunol Immunopathol; 1994 Nov; 43(4):337-55. PubMed ID: 7856070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic thymus response by kittens inoculated with feline immunodeficiency virus during fetal development.
    Johnson CM; Papadi GP; Tompkins WA; Sellon RK; Orandle MS; Bellah JR; Bubenik LJ
    Vet Pathol; 1998 May; 35(3):191-201. PubMed ID: 9598582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against feline immunodeficiency virus using fixed infected cells.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
    Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
    Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
    AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.